Security
TCGX Acquisition Corp. Class A Ordinary Shares · TCGX
TCGXNASDAQCommon stockCurrentCIK 2137965Updated Nov 11, 2026
TCGX price & chart
Loading TradingView…
NASDAQ:TCGX on TradingView ↗About the company
We are a newly organized blank check company incorporated as a Cayman Islands exempted company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
425 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
10-Q filing
Other Events
Items 8.01, 9.01
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Other Events
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
Offerings
Registration 333-297569
- Gross proceeds
- 75000000.0
- Net proceeds
- 70500000.0
- Deal price
- 10.0
- Shares
- 7500000
- Offering amount
- $75,000,000
- Offering price
- $10.00
- Ticker
- TCGX
Underwriters: Jefferies LLC
Filing attachments
d43527dex991.htm · 8-K · 2026-10-19
Exhibit 99.1 TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migraine Transaction Includes Concurrent $160 million Private Investment in Public Equity (PIPE) Financing and Expected Gross Proceeds of Approximately $246 million NEW YORK and PALO ALTO, CA - October 19, 2026 - TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-…
Read attachment ↗d43527dex992.htm · 8-K · 2026-10-19
A Novel Approach to Migraine October 2026 Exhibit 99.2 Disclaimers This presentation (this “Presentation”) has been prepared solely for the purpose of furnishing information on a confidential basis to interested parties to assist them in making their own evaluation with respect to a potential private placement of securities of TCGX Acquisition Corp. (“TCGX”) in connection with the contemplated business combination (the “Transaction”) between TCGX and TriGemX Bio, Inc. (the “Company” or “TriGemX…
Read attachment ↗d943201dex991.htm · 8-K · 2026-08-12
EX-99.1 2 d943201dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 INDEX TO FINANCIAL STATEMENT TCGX ACQUISITION CORP. PAGE Financial Statement of TCGX Acquisition Corp.: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of August 6, 2026 F-3 Notes to Financial Statement F-4 F-1 REPORT OF INDEPENDENT REGISTE…
Read attachment ↗d178859dex991.htm · 8-K · 2026-08-06
EX-99.1 10 d178859dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering Palo Alto, CA, August 4, 2026 - TCGX Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. Unlike certain other special purpose acquisition company initial public offerings, investors in this offering will not receive warrants that would become ex…
Read attachment ↗d178859dex992.htm · 8-K · 2026-08-06
EX-99.2 11 d178859dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 TCGX Acquisition Corp. Announces Completion of its Initial Public Offering Palo Alto, CA, August 6, 2026 - TCGX Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 8,625,000 Class A ordinary shares at a price of $10.00 per share, including the 1,125,000 shares issued pursuant to the full exercise by the underwriter of its over-allotment option. The Class A ordinary shares are listed on Th…
Read attachment ↗d85347dex107.htm · S-1 · 2026-07-20
EX-10.7 12 d85347dex107.htm EX-10.7 EX-10.7 Exhibit 10.7 PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT THIS PRIVATE PLACEMENT SHARES PURCHASE AGREEMENT, dated as of, 2026, (as it may from time to time be amended, this “Agreement”), is entered into by and between TCGX Acquisition Corp., a Cayman Islands exempted company (the “Company”), and TCGX Sponsor, LLC, a Delaware limited liability company (the “Purchaser”). WHEREAS, the Company intends to consummate an initial public offering (the “P…
Read attachment ↗